• About us

    The objective of our research program is to improve our understanding of the changes in the brain associated with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease. The lab works in close collaboration with the departments of biomedical engineering and computing science to develop and apply advanced brain imaging techniques.

    Read more
  • Amyotrophic Lateral Sclerosis

    Amyotrophic Lateral Sclerosis (also known as ALS, Lou Gehrig’s disease, or motor neuron disease) is a disease that gradually paralyzes people because the brain is no longer able to communicate with the muscles of the body that we are typically able to move at will.

    Read more
  • CALSNIC

    The Canadian ALS Neuroimaging Consortium (CALSNIC) was formed to create and evaluate new tests for ALS that use advanced MRI. CALSNIC has 7 participating sites in Canada and has recently branched internationally to include 2 sites in the US.

    Read more

Neuroimaging

Our lab uses advanced MRI techniques to study different aspects of brain degeneration, including diffusion tensor imaging, magnetic resonance spectroscopy, functional MRI, and quantitative structural imaging

Biomarkers

Our aim is to developing MRI-based biomarkers to aid in diagnosis, prognosis, and monitoring of disease progression in Amyotrophic Lateral Sclerosis (ALS) and related neurodegenerative disorders.

Multidisciplinary

Our research involves a multidisciplinary team consisting of neurologists, MR scientists, computing scientists, neuropathologists, biostatisticians, research staff, trainees and more.

About us

The objective of our research program is to improve our understanding of the changes in the brain associated with amyotrophic lateral sclerosis, also known as ALS or Lou Gehrig’s disease.

The lab works in close collaboration with scientists in the departments of biomedical engineering and computing science to develop and apply advanced brain imaging techniques to study different characteristics of brain involvement in ALS, including name changes in structure, chemistry, and function. These methods show immense promise in providing a biomarker, namely a test that can be used to detect disease earlier, monitor disease progression, and evaluate new therapies. Such a tool would accelerate drug testing and lead to the realization of effective treatment faster.

Training Opportunities

The lab is seeking students wishing to pursue graduate level degrees in Neuroscience, Computing Science, and Biomedical Engineering.

Join Us

Sponsors